Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Petrolympic Ltd PCQRF


Primary Symbol: V.PCQ

Petrolympic Ltd. is a Canada-based gold and lithium mining company. The Company is focused on its lithium exploration assets in the James Bay region, Basserode and Fourniere in Abitibi region as well as its gold exploration assets at Vauquelin and Rayon d’Or in the Val d’Or region, all in the Province of Quebec, Canada. The Li-1 and Li-2 Properties are located in the James Bay - Eeyou Itschee area, approximately 125 kilometers (km) north of the town of Chibougamau. The Basserode and Fourniere Lithium Properties are located in the Abitibi-Temiscamingue region, southwest of the Val d’Or mining camp, Quebec. Its Belcourt Property consists of 125 claims distributed in four blocks (Belcourt North, South, Central and West blocks), all proximal to one another and covering a total of 5,479 hectares. Its Rayon d’Or and Vauquelin Gold Properties are located within a gold mining camp in Northwestern Quebec, in the center of Vauquelin township (NTS 32C03), over 40 km east of the town of Val d’Or.


TSXV:PCQ - Post by User

Post by Rebeccaon Apr 15, 2022 9:10am
80 Views
Post# 34606222

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS Video


FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!

<< Previous
Bullboard Posts
Next >>